FDA: PROC MIXED (‼) for ABE [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2021-09-17 19:11 (923 d 15:31 ago) – Posting: # 22584
Views: 2,592

Dear Mahmoud!

Dear Dr Helmut


Not a doctor. No intentions to become one. Told you that numerous times before.

❝ If SAS® is used for statistical analysis

❝ PROC MIXED should be used for fully replicated (4-way) BE studies

❝ PROC GLM should be used for partially replicated (3-way) BE studies


Since you didn’t bother to read the entire thread as suggested – and not even the subject line of my post – would you mind to digest this one?

Your quote refers to Reference-scaled Average Bioequivalence (\(\small{s_\textrm{wR}\geq 0.294}\)).
However, for (conventional, unscaled) Average Bioequivalence (\(\small{s_\textrm{wR}<0.294}\)) PROC MIXED should be used regardless the design.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
122 visitors (1 registered, 121 guests [including 5 identified bots]).
Forum time: 09:42 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5